The evolution in the prioritization for liver transplantation
暂无分享,去创建一个
[1] J. Trotter,et al. The International Normalized Ratio (INR) in the MELD Score: Problems and Solutions , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] N. Madias,et al. Serum creatinine and renal function. , 1988, Annual review of medicine.
[3] D. Valla,et al. Assessment of Prognosis of Cirrhosis , 2008, Seminars in liver disease.
[4] J. Neuberger. The introduction of MELD‐based organ allocation impacts 3‐month survival after liver transplantation by influencing pretransplant patient characteristics , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[5] S. Sherlock,et al. Portal-systemic encephalopathy; neurological complications of liver disease. , 1954, Lancet.
[6] I. Colle,et al. Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective , 2005, European journal of gastroenterology & hepatology.
[7] E. Cholongitas,et al. Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? , 2005, Alimentary pharmacology & therapeutics.
[8] J. Tuttle-Newhall,et al. Disparities in liver transplantation before and after introduction of the MELD score. , 2008, JAMA.
[9] W. Chapman,et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function1 , 2004, Transplantation.
[10] T. Therneau,et al. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. , 2011, Gastroenterology.
[11] C. Sabin,et al. Towards a better liver transplant allocation system , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] J. Kalbfleisch,et al. Survival Benefit‐Based Deceased‐Donor Liver Allocation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] R. Wolfe,et al. Longitudinal assessment of mortality risk among candidates for liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] D. E. Schaubela,et al. The Survival Benefit of Deceased Donor Liver Transplantation as a Function of Candidate Disease Severity and Donor Quality , 2008 .
[15] D. Valla,et al. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. , 2005, Journal of hepatology.
[16] Mohamed Rela,et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] June-Sung Lee,et al. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month]. , 2007, The Korean journal of hepatology.
[18] M. Lucey. How will patients be selected for transplantation in the future? , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] Laura Marelli,et al. Different methods of creatinine measurement significantly affect MELD scores , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[20] T. Gonwa,et al. Continued Influence of Preoperative Renal Function on Outcome of Orthotopic Liver Transplant (OLTX) in the US: Where Will MELD Lead Us? , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] R. Adam,et al. Liver transplantation: the current situation. , 2009, Seminars in liver disease.
[22] C. Pilette,et al. Comparison and Improvement of MELD and Child-Pugh Score Accuracies for the Prediction of 6-month Mortality in Cirrhotic Patients , 2009, Journal of clinical gastroenterology.
[23] F L Grover,et al. Development of the New Lung Allocation System in the United States , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[24] E. Messou,et al. Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. , 2008, World journal of gastroenterology.
[25] R. Wiesner,et al. Results of the first year of the new liver allocation plan , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[27] A. Gimson,et al. Development of a UK score for patients with end-stage liver disease , 2007 .
[28] T. Therneau,et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.
[29] E. Vittinghoff,et al. Ascites improves upon plus serum sodium model for end‐stage liver disease (MELD) for predicting mortality in patients with advanced liver disease , 2009, Alimentary pharmacology & therapeutics.
[30] E. Cholongitas,et al. Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[31] A. Burroughs,et al. Towards a better liver allocation system. , 2009, Journal of hepatology.
[32] F. Villamil,et al. Who should get a liver graft? , 2009, Journal of hepatology.
[33] Samantha C Huo,et al. Comparison of four model for end‐stage liver disease–based prognostic systems for cirrhosis , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[34] E. Cholongitas,et al. Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores—A Systematic Bias , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[35] S. Sherlock,et al. Control of ascites in hepatic cirrhosis. , 1954, Lancet.
[36] J. Bosch,et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[37] J. Perkins,et al. D‐MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] M. Masetti,et al. Survival Benefit After Liver Transplantation: A Single European Center Experience , 2009, Transplantation.
[39] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[40] R. Wiesner. Patient selection in an era of donor liver shortage: current US policy , 2005, Nature Clinical Practice Gastroenterology &Hepatology.
[41] J J Fung,et al. Liver Transplantation in the United States, 1999–2008 , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[42] R. Pugh,et al. Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.
[43] A. Burroughs,et al. Selection of patients for liver transplantation and allocation of donated livers in the UK , 2007, Gut.
[44] Samantha C Huo,et al. Is the Corrected-Creatinine Model for End-Stage Liver Disease a Feasible Strategy to Adjust Gender Difference in Organ Allocation for Liver Transplantation? , 2007, Transplantation.
[45] M. Bartels,et al. Overview of the MELD score and the UNOS adult liver allocation system. , 2007, Transplantation proceedings.
[46] C. Sima,et al. Re-weighting the model for end-stage liver disease score components. , 2008, Gastroenterology.
[47] M. Biselli,et al. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[48] J. Bragg-Gresham,et al. Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[49] N D Heaton,et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease , 2006, Gut.
[50] M. Navasa,et al. Clinically relevant differences in the model for end‐stage liver disease and model for end‐stage liver disease–sodium scores determined at three university‐based laboratories of the same area , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[51] T M Therneau,et al. A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.
[52] N. Madias,et al. Serum creatinine as an index of renal function: new insights into old concepts. , 1992, Clinical chemistry.
[53] D. Shawcross,et al. Meld score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007 .
[54] A. Tripodi,et al. The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation , 2007, Hepatology.
[55] F. Chang,et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. , 2005, Journal of hepatology.
[56] R. Fisher,et al. MELD‐XI: A rational approach to “sickest first” liver transplantation in cirrhotic patients requiring anticoagulant therapy , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[57] W. Kim,et al. Is the change in MELD score a better indicator of mortality than baseline MELD score? , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[58] G. Auzinger,et al. Increased model for end‐stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[59] A. Gimson,et al. Elective Liver Transplant List Mortality: Development of a United Kingdom End-Stage Liver Disease Score , 2011, Transplantation.
[60] P. Terasaki,et al. Liver transplantation in the United States. , 2005, Clinical transplants.
[61] C. Sabin,et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome , 2006, The Lancet.
[62] R. Freeman. Mathematical Models and Behavior: Assessing Delta MELD for Liver Allocation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[63] J. Neuberger. Allocation of donor livers — is MELD enough? , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[64] A. Burroughs,et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.
[65] T. Therneau,et al. Predicting Survival among Patients Listed for Liver Transplantation: An Assessment of Serial MELD Measurements , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[66] W. Kim,et al. Organ allocation for chronic liver disease: model for end-stage liver disease and beyond , 2010, Current opinion in gastroenterology.
[67] J. Trotter,et al. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[68] A. Burroughs,et al. Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[69] Giacomo Germani,et al. Prioritization for liver transplantation , 2010, Nature Reviews Gastroenterology &Hepatology.
[70] Laura Marelli,et al. A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[71] Y. Cho,et al. Model for end‐stage liver disease, model for end‐stage liver disease‐sodium and Child–Turcotte–Pugh scores over time for the prediction of complications of liver cirrhosis , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[72] V. Arroyo,et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation , 2007, Gut.
[73] E. Christensen. Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? , 2004, Journal of hepatology.
[74] R. Wolfe,et al. The Survival Benefit of Liver Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[75] E. Cholongitas,et al. Review article: renal function assessment in cirrhosis – difficulties and alternative measurements , 2007, Alimentary pharmacology & therapeutics.
[76] G. Ioannou,et al. Development and validation of a model predicting graft survival after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.